Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
structure in first source
isolated from Okinawan sponge Acanthella sp.; structure in first source
from Aconitum anthora; structure in first source
isolated from the roots of Catharanthus roseus; structure in first source
isolated from the roots of Catharanthus roseus; structure in first source
structure in first source
a radiotracer; structure in first source
structure in first source
from Botrytis cinerea; structure in first source
structure in first source
covers 10 of approximately 90 S. pneumoniae serotypes
glycosylated mycosporine-like amino acid with radical scavenging activity from the cyanobacterium Nostoc commune; structure in first source
has free radical scavenging activity; isolated from Streptomyes; structure in first source
- C57644610alpha,18-epoxy-10beta-hydroxy-9-oxo-2alpha,5alpha,14beta-triacetoxytaxa-4(20),11(12)-dieneMeSH
furantaxane with an unusual 6/8/6/5 ring system and potent tumor MDR reversal activity obtained via microbial transformation by Streptomyces griseus; structure in first source
from the seeds of Taxus cuspidata; structure in first source
from Antiaris toxicaria
elaiophylin derivative from the marine-derived actinomycete Streptomyces sp. 7-145; structure in first source
elaiophylin derivative from the marine-derived actinomycete Streptomyces sp. 7-145; structure in first source
from Inula racemosa; structure in first source
from cultures of the basidiomycete Agaricus arvensis; structure in first source
an antifungal agent isolated from the coral Junceellajuncea; structure in first source
structure in first source
inhibits VEGF-R (TIE-2); structure in first source
A group of corticosteroids bearing a hydroxy group at the 11-position.
A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors.
An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.
Hydroxysteroid dehydrogenases that catalyzes the reversible conversion of CORTISOL to the inactive metabolite CORTISONE. Enzymes in this class can utilize either NAD or NADP as cofactors.
has antineoplastic activity; isolated from Sinularia leptoclados; structure in first source
analog of sibutramine; structure in first source
structure in first source
isolated from the fermentation broth of Streptomyces sp.; structure in first source
structure in first source
from the stem bark of Vitex doniana; structure in first source
metabolite of canrenone; structure in first source
structure in first source
structure in first source
immunosuppressant from Gelsemium elegans; structure in first source
from the leaves of Turpinia arguta (Lindl.) Seem; structure in first source
antineoplastic from Ambavia gerrardii from the Madagascar Dry Forest; structure in first source
structure in first source
structure in first source
from Caesalpinia volkensii; structure in first source
has antineoplastic activity; structure in first source
- C580870111In-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA(0)),1-Nal(3),Thr(8))octreotideMeSH
structure in first source
for imaging CD140b antigen
structure in first source
a radiotracer
an Auger electron-emitting radioimmunotherapeutic agent derived from monoclonal antibody 7G3 that is modified with peptides containing the nuclear translocation sequence of SV-40 large T-antigen
a radiopharmaceutical and imaging agent